JMCR and Cases Journal return to BioMed Central's publishing portfolio

NewsGuard 100/100 Score

BioMed Central is once again publishing the Journal of Medical Case Reports (JMCR) and Cases Journals. Since their inception, both these journals, which currently provide over 2000 freely accessible case reports have received widespread recognition and high quality submissions from across the medical community.  Through their innovative approach, both these journals make each individual patient's case a valuable addition to medical literature.

Professor Michael Kidd from Flinders University in Australia and Editor-in-Chief of JMCR said: "It's great to be back with BioMed Central. We have published many landmark clinical cases across all areas of medicine including cancer, ophthalmology, primary care, gastroenterology, infectious diseases, and musculoskeletal disorders that have significantly contributed to medical knowledge." These cases can often serve as early warning signals for the adverse effects of new medications, or the presentations of new and emerging diseases.  Cases Journal which is edited by regular Guardian columnist Richard Smith, will look to complete the scientific record for future generations by publishing any report that is understandable, ethical, authentic, and includes all information essential to its interpretation.

Over the past few years, authors have submitted case reports to these journals from countries as far afield as Nepal and Iran. This once again signifies the inherent value that case reports have to improving clinical practice globally and also the increasing power of the Internet to allow for the widespread sharing of knowledge and thus the advancement of the understanding and treatment of diseases.

Speaking of the return of JMCR and Cases Journal to BioMed Central's publishing portfolio Deborah Kahn, Publishing Director, said: "As the clinical significance and use of case reports continues to grow, the return of these two journals significantly bolsters BioMed Central's growing journal portfolio, and demonstrates our continued commitment to ensuring all research remains freely accessible all."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.